B2M and type 1 diabetes mellitus: The functional alterations in T1D islet α cells were accompanied by upregulation of immune signaling transcripts (e.g., HLA-A/B/C and B2M), dysregulation of mTOR signaling, and lysosomal imbalance, all of which likely contribute to aberrant glucagon release.